Warning: The NCBI web site requires JavaScript to function. more...
Effects of lovastatin on breast cancer cells: a proteo-metabonomic study.
Klawitter J, Shokati T, Moll V, Christians U, Klawitter J.
Breast Cancer Res. 2010;12(2):R16. Epub 2010 Mar 5.
Related citations
[Effects of lovastatin on cell cycle distribution in MCF-7 cells transfected with BRCA1].
Luo YQ, Mi MT, Wei N, Xu HX, Zhu JD.
Ai Zheng. 2004 Aug;23(8):924-8. Chinese.
Proteomics to display lovastatin-induced protein and pathway regulation in rat liver.
Steiner S, Gatlin CL, Lennon JJ, McGrath AM, Aponte AM, Makusky AJ, Rohrs MC, Anderson NL.
Electrophoresis. 2000 Jun;21(11):2129-37.
Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomas.
Dimitroulakos J, Marhin WH, Tokunaga J, Irish J, Gullane P, Penn LZ, Kamel-Reid S.
Neoplasia. 2002 Jul-Aug;4(4):337-46.
Bezielle (BZL101)-induced oxidative stress damage followed by redistribution of metabolic fluxes in breast cancer cells: a combined proteomic and metabolomic study.
Klawitter J, Klawitter J, Gurshtein J, Corby K, Fong S, Tagliaferri M, Quattrochi L, Cohen I, Shtivelman E, Christians U.
Int J Cancer. 2011 Dec 15;129(12):2945-57. doi: 10.1002/ijc.25965. Epub 2011 Apr 20.
BRCA1 overexpression sensitizes cancer cells to lovastatin via regulation of cyclin D1-CDK4-p21WAF1/CIP1 pathway: analyses using a breast cancer cell line and tumoral xenograft model.
Yu X, Luo Y, Zhou Y, Zhang Q, Wang J, Wei N, Mi M, Zhu J, Wang B, Chang H, Tang Y.
Int J Oncol. 2008 Sep;33(3):555-63.
Cell-cycle gene expression in lovastatin-induced medulloblastoma apoptosis.
Wang W, Macaulay RJ.
Can J Neurol Sci. 2003 Nov;30(4):349-57.
Survivin down-regulation plays a crucial role in 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor-induced apoptosis in cancer.
Kaneko R, Tsuji N, Asanuma K, Tanabe H, Kobayashi D, Watanabe N.
J Biol Chem. 2007 Jul 6;282(27):19273-81. Epub 2007 May 1.
In vitro mechanisms of lovastatin on lung cancer cell lines as a potential chemopreventive agent.
Maksimova E, Yie TA, Rom WN.
Lung. 2008 Jan-Feb;186(1):45-54. Epub 2007 Nov 22.
Synergistic effects of lovastatin and celecoxib on caveolin-1 and its down-stream signaling molecules: Implications for colon cancer prevention.
Guruswamy S, Rao CV.
Int J Oncol. 2009 Nov;35(5):1037-43.
Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells.
Bouterfa HL, Sattelmeyer V, Czub S, Vordermark D, Roosen K, Tonn JC.
Anticancer Res. 2000 Jul-Aug;20(4):2761-71.
Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice.
Ajith TA, Harikumar KB, Thasna H, Sabu MC, Babitha NV.
Clin Chim Acta. 2006 Apr;366(1-2):322-8. Epub 2005 Dec 27.
Potentiated antitumor effects of the combination treatment with statins and pamidronate in vitro and in vivo.
Issat T, Nowis D, Legat M, Makowski M, Klejman MP, Urbanski J, Skierski J, Koronkiewicz M, Stoklosa T, Brzezinska A, Bil J, Gietka J, Jakóbisiak M, Golab J.
Int J Oncol. 2007 Jun;30(6):1413-25.
Breast cancer growth prevention by statins.
Campbell MJ, Esserman LJ, Zhou Y, Shoemaker M, Lobo M, Borman E, Baehner F, Kumar AS, Adduci K, Marx C, Petricoin EF, Liotta LA, Winters M, Benz S, Benz CC.
Cancer Res. 2006 Sep 1;66(17):8707-14.
Simvastatin and lovastatin inhibit breast cell invasion induced by H-Ras.
Kang S, Kim ES, Moon A.
Oncol Rep. 2009 May;21(5):1317-22.
Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications.
Dimitroulakos J, Ye LY, Benzaquen M, Moore MJ, Kamel-Reid S, Freedman MH, Yeger H, Penn LZ.
Clin Cancer Res. 2001 Jan;7(1):158-67.
Lovastatin-induced E2F-1 modulation and its effect on prostate cancer cell death.
Park C, Lee I, Kang WK.
Carcinogenesis. 2001 Oct;22(10):1727-31.
The role of geranylgeranylated proteins in human mesangial cell proliferation.
Khwaja A, Sharpe CC, Noor M, Hendry BM.
Kidney Int. 2006 Oct;70(7):1296-304. Epub 2006 Aug 23.
Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer.
Zhang D, Tai LK, Wong LL, Chiu LL, Sethi SK, Koay ES.
Mol Cell Proteomics. 2005 Nov;4(11):1686-96. Epub 2005 Jul 26.
The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
Kodach LL, Bleuming SA, Peppelenbosch MP, Hommes DW, van den Brink GR, Hardwick JC.
Gastroenterology. 2007 Oct;133(4):1272-81. Epub 2007 Aug 14.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on